Le cluster Somatostatin (analogs & derivatives) - Somatostatin (diagnostic use)
| 000058 (2009) | Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multi-center French study. | |
| 000114 (2005) | Intraoperative and postoperative gamma detection of somatostatin receptors in bone-invasive en plaque meningiomas. | |
| 000154 (2000) | Somatostatin receptor in breast cancer and axillary nodes: study with scintigraphy, histopathology and receptor autoradiography. | |
| 000162 (1999) | Somatostatin receptor scintigraphy to predict the clinical evolution and therapeutic response of thyroid-associated ophthalmopathy. | |
| 000168 (1999) | Factor analysis of dynamic series (FADS) in somatostatin receptor imaging. | |
| 000170 (1999) | Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy. | |
| 000172 (1999) | Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy. | |
| 000175 (1998) | Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake. | |
| 000211 (1995) | Somatostatin receptor imaging: a preliminary experience in forty-nine patients. | |
| 000046 (2010) | [Somatostatin receptor-based imaging and therapy of digestive endocrine tumors]. | |
| 000060 (2009) | Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors. | |
| 000076 (2008) | Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors. | |
| 000081 (2008) | Chemical and biological evaluations of an (111)in-labeled RGD-peptide targeting integrin alpha(V) beta(3) in a preclinical tumor model. | |
| 000085 (2007) | Paraneoplastic ACTH secretion: bronchial carcinoid overlooked by planar indium-111 pentetreotide scintigraphy and accurately localized by SPECT/CT acquisition. | |
| 000087 (2007) | In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer. | |
| 000106 (2006) | Bone metastases from head and neck paragangliomas: uncommon MR findings in an uncommon condition--report of three cases. | |
| 000107 (2006) | (99m)Tc-annexin V and (111)In-antimyosin antibody uptake in experimental myocardial infarction in rats. | |
| 000110 (2005) | Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies. | |
| 000125 (2004) | Diagnostic management of suspected metastatic thyroid carcinoma: clinical value of octreotide scintigraphy in patients with negative high-dose radioiodine scans. | |
| 000130 (2003) | Octreotide imaging plus bone scintigrams to optimally localize gastroenteropancreatic neuroendocrine tumors. | |
| 000135 (2002) | [Scintigraphy by l'Octreoscan in the management of head and neck paragangliomas]. | |
| 000140 (2002) | Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy. | |
| 000142 (2001) | Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis. | |
| 000180 (1998) | In vivo inaccessibility of somatostatin receptors to 111In-pentreotide in primary renal cell carcinoma. | |
| 000191 (1997) | False-positive somatostatin receptor scintigraphy due to an accessory spleen. | |
| 000193 (1997) | Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. | |
| 000200 (1996) | Left ventricular myocardial uptake of a labeled somatostatin analog in carcinoid syndrome. | |
| 000207 (1996) | Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma. | |
| 000213 (1995) | Radiolabeled somatostatin analog scintigraphy in differentiated thyroid carcinoma. | |
| 000217 (1995) | Indium-111 pentetreotide scintigraphy in malignant lymphomas. | |
| 000225 (1994) | Somatostatin receptor imaging in non-functioning pituitary adenomas: value of an uptake index. | |
| 000093 (2006) | [Imaging strategy for staging and follow-up of endocrine tumors]. | |
| 000117 (2005) | Endocrine tumours of the gastrointestinal tract. Somatostatin receptors as tools for diagnosis and therapy: molecular aspects. | |
| 000134 (2003) | Clinical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and neck. | |
| 000136 (2002) | Parathyroid adenoma visualization on octreotide scintigraphy. | |
| 000147 (2001) | Indium-111 octreotide scintigraphy of Merkel cell carcinomas and their metastases. | |
| 000158 (2000) | 111In-pentetreotide scintigraphy in patients with Langerhans' cell histiocytosis. | |
| 000163 (1999) | Somatostatin receptor scintigraphy in pituitary adenomas: a somatostatin receptor density index can predict hormonal and tumoral efficacy of octreotide in vivo. | |
| 000165 (1999) | In-111 pentetreotide scintigraphy to monitor nonsecreting neuroendocrine tumors. | |
| 000182 (1997) | [Peroperative detection probes. Evaluation and perspectives in endocrinology]. | |
| 000189 (1997) | Internalization of indium-labeled LDL through a lipid chelating anchor in human pancreatic-cancer cells as a potential radiopharmaceutical for tumor localization. | |
| 000202 (1996) | Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors. | |
| 000205 (1996) | Could somatostatin scintigraphy be superior to MIBG scan in the staging of stage IVs neuroblastoma (Pepper's syndrome)? | |
| 000214 (1995) | Per operative localization of a carcinoid tumour of the breast using indium-111 pentetreotide and a nuclear surgical probe. | |
| 000223 (1994) | Strong uptake of 111In-pentetreotide by an MIBG-negative, xenografted neuroblastoma. | |
| 000226 (1994) | Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor. | |
| 000227 (1994) | Scintiscans and carcinoid tumors. | |
| 000007 (2013) | Sustained therapeutic perfusion outside transplanted sites in chronic myocardial infarction after stem cell transplantation. | |
| 000020 (2012) | Reduction of renal uptake of 111In-DOTA-labeled and A700-labeled RAFT-RGD during integrin αvβ3 targeting using single photon emission computed tomography and optical imaging. | |
| 000075 (2008) | Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy. | |
| 000102 (2006) | Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis. | |
| 000108 (2005) | Validation of the Monte Carlo simulator GATE for indium-111 imaging. | |
| 000121 (2004) | The usefulness of 99mTc sulfur colloid bone marrow scintigraphy combined with 111In leucocyte scintigraphy in prosthetic joint infection. | |
| 000138 (2002) | Labelled oligonucleotides as radiopharmaceuticals: pitfalls, problems and perspectives. | |
| 000149 (2001) | Gastric emptying is accelerated in obese type 2 diabetic patients without autonomic neuropathy. | |
| 000157 (2000) | Experimental radiation pneumonitis studied with indium-111-pentetreotide. | |
| 000161 (1999) | Subarachnoid-pleural fistula complicating thoracoscopy: value of In-111 DTPA myeloscintigraphy. | |
| 000167 (1999) | False-positive antimyosin imaging caused by cardioversion-induced skeletal muscle uptake. | |
| 000173 (1999) | Cell irradiation caused by diagnostic nuclear medicine procedures: dose heterogeneity and biological consequences. | |
| 000186 (1997) | Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne. | |
| 000194 (1996) | [Detection of endocrine tumors of the digestive tract. Value and limitations of scintigraphy of somatostatin receptors]. | |
| 000199 (1996) | Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan. | |
| 000224 (1994) | Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison. |
| This area was generated with Dilib version V0.5.76. |  |